BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 32045269)

  • 1. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
    Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
    Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.
    Ding H; Zhang L; Zhang C; Song J; Jiang Y
    Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.
    Dong A; Xu B; Wang Z; Miao X
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer.
    Xia Q; Jin H; Zhang X; Yan W; Meng D; Ding B; Cao J; Li D; Wang S
    Int Immunopharmacol; 2020 Nov; 88():106935. PubMed ID: 32889244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
    Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
    Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
    Kwon EJ; Ha M; Jang JY; Kim YH
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
    Mao R; Chen Y; Xiong L; Liu Y; Zhang T
    Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
    Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
    DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
    Ouyang D; Li R; Li Y; Zhu X
    J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy-related long non-coding RNA signature for potential prognostic biomarkers of patients with cervical cancer: a study based on public databases.
    Feng Q; Wang J; Cui N; Liu X; Wang H
    Ann Transl Med; 2021 Nov; 9(22):1668. PubMed ID: 34988177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer.
    Lang X; Huang C; Cui H
    J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.